A single nucleotide substitution introduces a premature termination codon into the androgen receptor gene of a patient with receptor-negative androgen resistance.

Marco Marcelli, Wayne D. Tilley, Carol M. Wilson, Jean D. Wilson, Jim E. Griffin, Michael J. McPhaulJournal of Clinical Investigation 1990 · DOI

Abstract

Mutations in the androgen receptor (AR) gene that impair hormone action lead to abnormal male sexual development. This study investigated nine patients with receptor-negative androgen resistance, where 5α-dihydrotestosterone (DHT) binding is absent despite a seemingly intact gene. Using PCR and sequence analysis, we identified a single nucleotide substitution (G to A) in exon 6 of one patient (N750). This mutation creates a premature termination codon at amino acid 794, resulting in a truncated, non-functional receptor protein.

Introduction

Androgen Insensitivity Syndrome (AIS) encompasses a spectrum of disorders where individuals with a 46,XY karyotype exhibit varying degrees of feminization due to defects in the androgen receptor. While some cases involve large gene deletions, many "receptor-negative" patients show no gross genomic alterations. This research aimed to pinpoint the subtle molecular defects responsible for complete androgen resistance in these individuals.

Genomic Integrity Across Patients

Initial analysis focused on determining if large-scale structural changes were present in the AR gene. Using labeled probes specific to each coding exon, the researchers performed Southern blotting on DNA from nine unrelated patients.

Figure 2: Southern blot analysis of the androgen receptor gene across nine patients, showing no gross rearrangements or deletions in exons 1-8.

As shown in Figure 2, the hybridization patterns for exons 1 through 8 were identical across all patients and healthy controls. This confirmed that the resistance was not due to the absence of the gene or major rearrangements, suggesting instead that small-scale mutations were the likely cause.

Identification of a Premature Stop Codon

To find these subtle changes, the team amplified each exon using PCR and performed nucleotide sequencing. In patient N750, a critical "typo" was discovered in exon 6.

Figure 4: Nucleotide sequence analysis of the AR gene in patient N750 compared to a normal control. A G-to-A substitution converts a tryptophan codon (TGG) into a stop codon (TGA) at position 794.

The sequence analysis (Figure 4) revealed a single guanosine to adenosine substitution. In the genetic code, this changes the codon for tryptophan (TGG) at position 794 into a premature termination codon (TGA). This "stop sign" occurs 122 amino acids before the natural end of the protein.

Functional Consequences

Despite the premature stop codon, S1 nuclease protection assays showed that AR mRNA levels in the patient's fibroblasts were normal. Furthermore, when the mutated cDNA was transfected into eukaryotic cells, a truncated protein was produced in normal amounts. However, this shortened receptor, missing a significant portion of its steroid-binding domain, was completely unable to bind DHT. Immunoblotting confirmed the mutant receptor was approximately 11 kD smaller than the normal 110 kD receptor, consistent with the loss of 122 amino acids.

Conclusion

The discovery of a single nucleotide substitution in patient N750 demonstrates that even the smallest genetic alteration can lead to complete androgen resistance. This study highlights the importance of high-resolution sequencing in diagnosing AIS and suggests that "receptor-negative" resistance is a genetically heterogeneous condition driven by various point mutations rather than a single common defect.

Summary updated

Abstract

Mutations of the androgen receptor that impair the action of 5 alpha-dihydrotestosterone and testosterone result in abnormal male sexual development. The definition of the organization of the androgen receptor gene has permitted us to examine its structure in nine patients with androgen resistance that exhibit absent 5 alpha-dihydrotestosterone binding in cultured fibroblasts (receptor-negative androgen resistance). Using labeled probes specific for each individual coding exon, we find no gross rearrangements, insertions, or deletions of the androgen receptor gene in these patients. To analyze the genetic defect in these receptor-negative patients, we used the polymerase chain reaction to amplify each individual exon of the androgen receptor gene in nine affected patients. In all patients, the size of each amplified exon segment was identical to that in normal individuals. The nucleotide sequence of the entire coding region of the androgen receptor was determined in one of these patients. A single nucleotide substitution was identified that results in a premature termination codon in exon 6 at amino acid 794. S1 nuclease protection assays demonstrated that normal levels of androgen receptor mRNA are present in skin fibroblasts of this patient. Transfection of a mutated androgen receptor cDNA containing a termination codon at position 794 into eukaryotic cells resulted in formation of a normal amount of receptor protein, as indicated by immunoblotting, but the expressed protein does not bind 5 alpha-dihydrotestosterone. These findings suggest that the presence of a premature termination codon at amino acid 794 of the androgen receptor is the cause of androgen resistance in this patient.
BibTeX
@article{marcelli1990single,
  author = {Marco Marcelli and Wayne D. Tilley and Carol M. Wilson and Jean D. Wilson and Jim E. Griffin and Michael J. McPhaul},
  title = {{A single nucleotide substitution introduces a premature termination codon into the androgen receptor gene of a patient with receptor-negative androgen resistance.}},
  journal = {Journal of Clinical Investigation},
  year = {1990},
  doi = {10.1172/jci114599},
}
Figure